|
Published by: GlobalData
Published: Nov. 20, 2012 - 180 Pages
Table of Contents- Introduction
- Chronic Obstructive Pulmonary Disease (COPD)
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Chronic Obstructive Pulmonary Disease (COPD)
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- GlaxoSmithKline plc
- Clinical Trial Overview of GlaxoSmithKline plc
- AstraZeneca PLC
- Clinical Trial Overview of AstraZeneca PLC
- Boehringer Ingelheim GmbH
- Clinical Trial Overview of Boehringer Ingelheim GmbH
- Novartis AG
- Clinical Trial Overview of Novartis AG
- Chiesi Farmaceutici SpA
- Clinical Trial Overview of Chiesi Farmaceutici SpA
- Pfizer Inc.
- Clinical Trial Overview of Pfizer Inc.
- Almirall, S.A.
- Clinical Trial Overview of Almirall, S.A.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Clinical Trial Overview of Boehringer Ingelheim Pharmaceuticals, Inc.
- Sunovion Pharmaceuticals Inc.
- Clinical Trial Overview of Sunovion Pharmaceuticals Inc.
- Novartis Pharmaceuticals Corporation
- Clinical Trial Overview of Novartis Pharmaceuticals Corporation
- Merck & Co., Inc.
- Clinical Trial Overview of Merck & Co., Inc.
- Forest Laboratories, Inc.
- Clinical Trial Overview of Forest Laboratories, Inc.
- Dey Pharma, L.P.
- Clinical Trial Overview of Dey Pharma, L.P.
- Pearl Therapeutics, Inc.
- Clinical Trial Overview of Pearl Therapeutics, Inc.
- Aeris Therapeutics, Inc.
- Clinical Trial Overview of Aeris Therapeutics, Inc.
- Bayer AG
- Clinical Trial Overview of Bayer AG
- Takeda Global Research and Development Center, Inc
- Clinical Trial Overview of Takeda Global Research and Development Center, Inc
- MedImmune, LLC
- Clinical Trial Overview of MedImmune, LLC
- Glittreklinikken AS (LHL)
- Clinical Trial Overview of Glittreklinikken AS (LHL)
- Cipla Ltd.
- Clinical Trial Overview of Cipla Ltd.
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Imperial College London
- Clinical Trial Overview of Imperial College London
- Katholieke Universiteit Leuven
- Clinical Trial Overview of Katholieke Universiteit Leuven
- Laval University
- Clinical Trial Overview of Laval University
- Klinikum Berchtesgadener Land der Schon-Kliniken
- Clinical Trial Overview of Klinikum Berchtesgadener Land der Schon-Kliniken
- Radboud University
- Clinical Trial Overview of Radboud University
- Norwegian University of Science and Technology
- Clinical Trial Overview of Norwegian University of Science and Technology
- University Hospital Basel
- Clinical Trial Overview of University Hospital Basel
- Queen's University
- Clinical Trial Overview of Queen's University
- Weill Cornell Medical College
- Clinical Trial Overview of Weill Cornell Medical College
- University of Milan
- Clinical Trial Overview of University of Milan
- University Medical Center Groningen
- Clinical Trial Overview of University Medical Center Groningen
- Department of Health, UK
- Clinical Trial Overview of Department of Health, UK
- Universidade Federal de Sao Carlos
- Clinical Trial Overview of Universidade Federal de Sao Carlos
- The University of Sydney
- Clinical Trial Overview of The University of Sydney
- University of Pittsburgh
- Clinical Trial Overview of University of Pittsburgh
- University Hospital Freiburg
- Clinical Trial Overview of University Hospital Freiburg
- University of Dundee
- Clinical Trial Overview of University of Dundee
- Aarhus University
- Clinical Trial Overview of Aarhus University
- Medisch Spectrum Twente
- Clinical Trial Overview of Medisch Spectrum Twente
- Johns Hopkins University
- Clinical Trial Overview of Johns Hopkins University
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Zone, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, North America, Top Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, BRIC Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, G7 Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, E7 Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Phase, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Suspended Clinical Trials, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Terminated Clinical Trials, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Pharmaceuticals, Inc., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunovion Pharmaceuticals Inc., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dey Pharma, L.P., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pearl Therapeutics, Inc., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeris Therapeutics, Inc., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Global Research and Development Center, Inc, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Glittreklinikken AS (LHL), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cipla Ltd., 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laval University, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Klinikum Berchtesgadener Land der Schon-Kliniken, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal de Sao Carlos, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medisch Spectrum Twente, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
- List of Figures
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, BRIC Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, G7 Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, E7 Countries (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- GlobalData Methodology
AbstractChronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2012 provides data on the Chronic Obstructive Pulmonary Disease (COPD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Obstructive Pulmonary Disease (COPD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Get full details about this report >>
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports,
company profiles and country profiles from over 720 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
|
|
